Odink Debra

Anthera Pharmaceuticals Inc

Chief Technology Officer

Avg. Two Year Performance

(74%) Avg. Purchase Return (32%) Compound

95% Avg. Sale Return 40% Compound

Holdings: 21.75K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions